NCT04884256View on ClinicalTrials.gov

Safety and Efficacy Study of CBT-004 in Patients With Vascularized Pinguecula

PHASE2CompletedINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

December 21, 2023

Primary Completion Date

April 17, 2025

Study Completion Date

May 30, 2025

Conditions
Pinguecula
Interventions
DRUG

CBT-004

Dose response study

Trial Locations (1)

91204

Global Research Management, Glendale

Sponsors
All Listed Sponsors
lead

Cloudbreak Therapeutics, LLC

INDUSTRY